Latest Breaking News On - Dave brochu - Page 1 : comparemela.com

LONDON, March 12, 2024 (GLOBE NEWSWIRE) Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that following the most recent GMP

United statesUnited kingdomCity ofSusana noonanOlivia manserDave brochuJulia wilsonExchange commission onSa noonan communicationsExchange commissionAutolu nucleusImportation authorisationChief technology officerOrphan drug designationOrphan medical product designationRegenerative medicine advanced therapy